Delayed Prostate Cancer Therapy Hagerstown MD

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Alida Mercedes Espinoza
(301) 797-8279
1130 Opal Ct
Hagerstown, MD
Specialty
Hematology / Oncology

Data Provided by:
Dr.Hind Hamdan
(301) 797-8279
1130 Opal Court
Hagerstown, MD
Gender
F
Education
Medical School: American Univ Of Beirut, Fac Of Med, Beirut
Year of Graduation: 1985
Speciality
Oncologist
General Information
Hospital: Washington County Hospital, Hagerstown, Md
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 3, reviews.

Data Provided by:
Michael Joseph Mc Cormack, MD
(301) 733-8600
11110 Medical Campus Rd Ste 130
Hagerstown, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Georgetown Univ Sch Of Med, Washington Dc 20007
Graduation Year: 1982

Data Provided by:
Frederic Henry Kass III, MD
(301) 733-8607
11110 Medical Campus Rd Ste 130
Hagerstown, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: George Washington Univ Sch Of Med & Hlth Sci, Washington Dc 20037
Graduation Year: 1974

Data Provided by:
Robert Kent Finley
(717) 762-7155
45 Roadside Ave
Waynesboro, PA
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Hind Hamdan, MD
(301) 797-8279
1130 Opal Ct
Hagerstown, MD
Specialties
Oncology (Cancer), Internal Medicine
Gender
Female
Languages
Arabic
Education
Medical School: American Univ Of Beirut, Fac Of Med, Beirut, Lebanon
Graduation Year: 1985
Hospital
Hospital: Washington County Hospital, Hagerstown, Md

Data Provided by:
Dan Roger Cornell, MD
(301) 665-4650
11110 Medical Campus Rd Ste 129
Hagerstown, MD
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Md Sch Of Med, Baltimore Md 21201
Graduation Year: 1987

Data Provided by:
Michael J McCormack
(301) 733-8600
11110 Medical Campus Rd
Hagerstown, MD
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Gerald Stephen Brown, MD
(301) 824-3343
22911 Jefferson Blvd
Smithsburg, MD
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Ottawa, Fac Of Med, Ottawa, Ont, Canada
Graduation Year: 1963

Data Provided by:
Kenneth Alvin Bertra, MR
(301) 619-7071
1077 Patchel St MCMR-ZB C
Frederick, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com